Difference between revisions of "Part:BBa K1442039"
Line 17: | Line 17: | ||
<p>This aptazyme was included as an RNA kill switch We put this structure centrally in our replicon in order to cause the maxmimum disruption when activated with theophylline.</p> | <p>This aptazyme was included as an RNA kill switch We put this structure centrally in our replicon in order to cause the maxmimum disruption when activated with theophylline.</p> | ||
− | + | <html><body><img src="https://static.igem.org/mediawiki/2014/thumb/d/d9/MS2_Schematic.jpg/800px-MS2_Schematic.jpg"/></body></html> | |
− | + | ||
− | <html><body><img src="https://static.igem.org/mediawiki/2014/thumb/d/d9/MS2_Schematic.jpg/800px-MS2_Schematic.jpg | + | |
<!-- --> | <!-- --> |
Revision as of 22:15, 16 October 2014
P2A self-cleaving peptide sequence
The self-cleaving 2A peptide (18-22 amino acids) is a virally derived coding region that has been utilised by viruses to self-cleave during translation and is likely to have arisen to overcome traditional IRES sequences due to its much smaller coding length and allows for a smaller viral genome [1].
Of the available 2A coding regions coding for the peptide from various viruses: foot-and-mouth disease virus, equine rhinitis A, Thosea asigna, porcine teschovirus-1. The porcine teschovirus 2A (P2A) had the highest efficiency of cleavage in three mammalian cell lines tested by Kim et al [1]: human, zebrafish and adult mice.
The P2A peptide can be used in a research context to allow multicistronic expression of genes without traditional methods of: multiple promoters, insertion of a splicing signal, insertion of a proteolytic cleavage site (e.g. TEV) and IRESs. Of note, P2A overcomes the limitations of an IRES: it is much smaller and also improves the translational efficiency of IRES-based genes [1]. The use of P2A is therefore useful to allow coexpression of large proteins in plasmids where the size of the insert is limiting and preserves the authenicity of a expressed protein sequence over traditionally cleaved protein in vitro such as TEV protease sites that leave a scar site.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]